Atara Biotherapeutics, Inc. (ATRA) saw a big move last session, as the company’s shares fell nearly 15% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for ATRA as the stock is now up over 9% in the past one-month time frame.
This biopharmaceutical company has seen a flat track record when it comes to current year estimate revisions, as there has been no revision on either side over the past few weeks. The consensus for earnings estimate hasn’t been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
ATRA currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked stock in the same sector is China Biologic Products, Inc. (CBPO), holding a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment